1. ST8SIA6-AS1, a novel lncRNA star in liver cancer
- Author
-
Cheng Qiu, Haoran Fan, Siyu Tao, Ziqing Deng, Hongliang Luo, and Fangteng Liu
- Subjects
liver cancer ,ST8SIA6-AS1 ,tumorigenesis ,tumor biomarker ,therapeutic target ,Biology (General) ,QH301-705.5 - Abstract
Liver cancer is one of the most lethal gastrointestinal malignancies. Emerging evidence has underscored the pivotal role of long non-coding RNAs (lncRNAs) in tumorigenesis, with ST8SIA6-AS1 identified as a novel oncogenic lncRNA contributing to liver cancer progression. ST8SIA6-AS1 is consistently upregulated in hepatic cancer tissues and is strongly associated with unfavorable prognosis. Moreover, it demonstrates high diagnostic efficacy in detecting HCC. ST8SIA6-AS1 is involved in various cellular processes including proliferation, migration, and invasion, primarily through its function as a competing endogenous RNA (ceRNA), thereby facilitating hepatocarcinogenesis and disease advancement. This review provides a detailed examination of the molecular functions and regulatory mechanisms of ST8SIA6-AS1 in hepatocellular carcinoma (HCC) and highlights its potential as a promising biomarker for liver cancer, aiming to propel the development of innovative therapeutic strategies for HCC management.
- Published
- 2024
- Full Text
- View/download PDF